Cargando…
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
Traumatic brain injury is a common type of acquired brain injury of varying severity carrying potentially deleterious consequences for the afflicted individuals, families, and society. Following the initial, traumatically induced insult, cellular injury processes ensue. These are believed to be amen...
Autores principales: | Lindblad, Caroline, Rostami, Elham, Helmy, Adel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684479/ https://www.ncbi.nlm.nih.gov/pubmed/37610701 http://dx.doi.org/10.1007/s13311-023-01421-0 |
Ejemplares similares
-
Fluid-Based Protein Biomarkers in Traumatic Brain Injury: The View from the Bedside
por: Agoston, Denes V., et al.
Publicado: (2023) -
The Role of BDNF in Experimental and Clinical Traumatic Brain Injury
por: Gustafsson, David, et al.
Publicado: (2021) -
Cellular infiltration in traumatic brain injury
por: Alam, Aftab, et al.
Publicado: (2020) -
Recent advances in traumatic brain injury
por: Khellaf, Abdelhakim, et al.
Publicado: (2019) -
Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury
por: Thome, Jason G., et al.
Publicado: (2020)